Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended		84 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Revenues	$ 11		$ 20		$ 20
Cost of sales	8		179		179
Gross margin	3		(159)		(159)
Operating costs and expenses
Research and development	557	975	2,504	2,480	15,441
Selling, general and administrative	822	506	2,803	1,627	11,799
Total operating costs and expenses	1,379	1,481	5,307	4,107	27,240
Operating loss	(1,376)	(1,481)	(5,466)	(4,107)	(27,399)
Other income and expense
Other income					1,147
Interest income, net					79
Amortization of deferred financing cost	(2)	(5)	(7)	(36)	(1,977)
Interest expense		(7)	(43)	(7)	(155)
Total other income and expense	(2)	(12)	(50)	(43)	(906)
Loss before income tax	(1,378)	(1,493)	(5,516)	(4,150)	(28,305)
Provision for income tax
Net loss	(1,378)	(1,493)	(5,516)	(4,150)	(28,305)
Loss attributable to common stockholders and loss per common share:
Net loss	(1,378)	(1,493)	(5,516)	(4,150)	(28,305)
Net loss attributable to common stockholders	(1,378)	(1,493)	(5,516)	(4,150)	(33,672)
Weighted average shares outstanding, basic and diluted	48,798	28,004	45,155	28,004
Net loss per basic and diluted share	$ (0.03)	$ (0.05)	$ (0.12)	$ (0.15)
Series A Preferred Conversion
Loss attributable to common stockholders and loss per common share:
Deemed dividend					(4,301)
Series A Preferred Stock
Loss attributable to common stockholders and loss per common share:
Deemed dividend					(700)
Dividends - Series A Preferred Stock					$ (366)